Ticker

Materialise is poised for a return to consistent growth and improving margins, led by Medical strength and stabilization of its Software business. The Manufacturing segment faces ongoing headwinds, but expansion into aerospace and defense could create a modest rebound over the next few years. The combination of a low valuation, consistent growth, and higher margins should lead the stock higher, which will be…

Materialise NV (MTLS) Q4 2025 Earnings Call Transcript

LEUVEN, Belgium--(BUSINESS WIRE)---- $MTLS--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Highlights – Fourth Quarter 2025 Total revenue increased by 6.8% to 70,164 kEUR for the fourth quarter of 2025…

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the fourth quarter ended December 31, 2025 on Thursday, February 19, 2026 at 2:30 a.m. ET/8:30 a.m. CET. Senior management will hold a conference call to discuss…

Materialise NV (NASDAQ: MTLS - Get Free Report) shares crossed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $5.64 and traded as low as $5.59. Materialise shares last traded at $5.62, with a volume of 56,831 shares. Wall Street Analyst Weigh In Several equities research analysts